[Federal Register Volume 78, Number 173 (Friday, September 6, 2013)]
[Notices]
[Pages 54917-54919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-21744]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Cerilliant Corporation

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 10, 2013, Cerilliant 
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
4-Methyl-N-methylcathinone (1248)...........  I
N-Ethylamphetamine (1475)...................  I
N,N-Dimethylamphetamine (1480)..............  I
Fenethylline (1503).........................  I
Aminorex (1585).............................  I
4-Methylaminorex (cis isomer) (1590)........  I
Gamma Hydroxybutyric Acid (2010)............  I
Methaqualone (2565).........................  I
XLR11 (7011)................................  I
AKB48 (7048)................................  I
1-Pentyl-3-(1-naphthoyl)indole (7118).......  I
UR-144 (7144)...............................  I
1-Butyl-3-(1-naphthoyl)indole (7173)........  I
1-[2-(4-Morpholinyl)ethyl]-3-(1-              I
 naphthoyl)indole (7200).
Alpha-ethyltryptamine (7249)................  I
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-          I
 hydroxycyclohexyl-phenol] (7297).
5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-            I
 hydroxycyclohexyl-phenol] (7298).
Lysergic acid diethylamide (7315)...........  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine  I
 (7348).
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
Parahexyl (7374)............................  I
Mescaline (7381)............................  I
3,4,5-Trimethoxyamphetamine (7390)..........  I

[[Page 54918]]

 
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
2,5-Dimethoxy-4-ethylamphetamine (7399).....  I
3,4-Methylenedioxyamphetamine (7400)........  I
5-Methoxy-3,4-methylenedioxyamphetamine       I
 (7401).
N-Hydroxy-3,4-methylendioxyamphetamine        I
 (7402).
3,4-Methylendioxy-N-ethylamphetamine (7404).  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
5-Methoxy-N-N-dimethyltryptamine (7431).....  I
Alpha-methyltryptamine (7432)...............  I
Bufotenine (7433)...........................  I
Diethyltryptamine (7434)....................  I
Dimethyltryptamine (7435)...................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
5-Methoxy-N,N-diisopropyltryptamine (7439)..  I
N-Ethyl-1-phenylcyclohexylamine (7455)......  I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)....  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)  I
N-Benzylpiperazine (7493)...................  I
Acetyldihydrocodeine (9051).................  I
Benzylmorphine (9052).......................  I
Codeine-N-oxide (9053)......................  I
Codeine methylbromide (9070)................  I
Dihydromorphine (9145)......................  I
Heroin (9200)...............................  I
Hydromorphinol (9301).......................  I
Methyldesorphine (9302).....................  I
Methyldihydromorphine (9304)................  I
Morphine methylbromide (9305)...............  I
Morphine methylsulfonate (9306).............  I
Morphine-N-oxide (9307).....................  I
Normorphine (9313)..........................  I
Pholcodine (9314)...........................  I
Acetylmethadol (9601).......................  I
Allylprodine (9602).........................  I
Alphacetylmethadol except levo-               I
 alphacetylmethadol (9603).
Alphameprodine (9604).......................  I
Alphamethadol (9605)........................  I
Betacetylmethadol (9607)....................  I
Betameprodine (9608)........................  I
Betamethadol (9609).........................  I
Betaprodine (9611)..........................  I
Dipipanone (9622)...........................  I
Hydroxypethidine (9627).....................  I
Noracymethadol (9633).......................  I
Norlevorphanol (9634).......................  I
Normethadone (9635).........................  I
Trimeperidine (9646)........................  I
Phenomorphan (9647).........................  I
1-Methyl-4-phenyl-4-propionoxypiperidine      I
 (9661).
Tilidine (9750).............................  I
Para-Fluorofentanyl (9812)..................  I
3-Methylfentanyl (9813).....................  I
Alpha-Methylfentanyl (9814).................  I
Acetyl-alpha-methylfentanyl (9815)..........  I
Beta-hydroxyfentanyl (9830).................  I
Beta-hydroxy-3-methylfentanyl (9831)........  I
Alpha-methylthiofentanyl (9832).............  I
3-Methylthiofentanyl (9833).................  I
Thiofentanyl (9835).........................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Lisdexamfetamine (1205).....................  II
Phenmetrazine (1631)........................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Glutethimide (2550).........................  II
Nabilone (7379).............................  II

[[Page 54919]]

 
1-Phenylcyclohexylamine (7460)..............  II
Phencyclidine (7471)........................  II
1-Piperidinocyclohexanecarbonitrile (8603)..  II
Alphaprodine (9010).........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Diphenoxylate (9170)........................  II
Ecgonine (9180).............................  II
Ethylmorphine (9190)........................  II
Hydrocodone (9193)..........................  II
Levomethorphan (9210).......................  II
Levorphanol (9220)..........................  II
Isomethadone (9226).........................  II
Meperidine (9230)...........................  II
Meperidine intermediate-A (9232)............  II
Meperidine intermediate-B (9233)............  II
Meperidine intermediate-C (9234)............  II
Metazocine (9240)...........................  II
Methadone (9250)............................  II
Methadone intermediate (9254)...............  II
Dextropropoxyphene, bulk (non-dosage forms)   II
 (9273).
Morphine (9300).............................  II
Thebaine (9333).............................  II
Levo-alphacetylmethadol (9648)..............  II
Oxymorphone (9652)..........................  II
Noroxymorphone (9668).......................  II
Racemethorphan (9732).......................  II
Alfentanil (9737)...........................  II
Remifentanil (9739).........................  II
Sufentanil (9740)...........................  II
Carfentanil (9743)..........................  II
Tapentadol (9780)...........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards which will be 
distributed to their customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than November 5, 2013.

    Dated: August 29, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-21744 Filed 9-5-13; 8:45 am]
BILLING CODE 4410-09-P